Hemiparkinsonism with a discrete lacunar infarction in the contralateral substantia nigra.
Ohta
Kouichi
K
Obara
Katsuyuki
K
D000978:Antiparkinson Agents / Q000009:adverse effects / Q000627:therapeutic use; D020526:Brain Stem Infarctions / Q000175:diagnosis* / Q000503:physiopathology; D002230:Carbidopa / Q000009:adverse effects / Q000627:therapeutic use; D002544:Cerebral Infarction / Q000175:diagnosis* / Q000503:physiopathology; D003937:Diagnosis, Differential; D004292:Dominance, Cerebral / Q000502:physiology*; D004359:Drug Therapy, Combination; D005500:Follow-Up Studies; D006801:Humans; D007980:Levodopa / Q000009:adverse effects / Q000627:therapeutic use; D008279:Magnetic Resonance Imaging; D008297:Male; D008875:Middle Aged; D009460:Neurologic Examination; D020734:Parkinsonian Disorders / Q000175:diagnosis* / Q000188:drug therapy / Q000503:physiopathology; D013378:Substantia Nigra / Q000098:blood supply* / Q000503:physiopathology; D015899:Tomography, Emission-Computed, Single-Photon
D000978:Antiparkinson Agents; D007980:Levodopa; D002230:Carbidopa